Shiong’s portfolio saw a slight drop over past 12 months as the value of his stake in Culver City immunotherapy firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback